IRONWOOD PHARMACEUTICALS
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, and inflammation. The company's operationally independent subsidiary, Microbia Inc., engages in developing and commercializing bioprocesses for use in pharmaceuticals, foods, and specialty and industrial chemicals. Ironwood Pharmaceuticals, Inc. was formerly known as Microbia, Inc. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.
IRONWOOD PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.ironwoodpharma.com
Total Employee:
501+
Status:
Active
Contact:
617-621-7722
Email Addresses:
[email protected]
Total Funding:
634 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Polaris Partners
Polaris Partners investment in Venture Round - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series F - Ironwood Pharmaceuticals
Morgan Stanley
Morgan Stanley investment in Series F - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series E - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series D - Ironwood Pharmaceuticals
GGV Capital
GGV Capital investment in Series D - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series C - Ironwood Pharmaceuticals
F-Prime Capital
F-Prime Capital investment in Series C - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series B - Ironwood Pharmaceuticals
Venrock
Venrock investment in Series A - Ironwood Pharmaceuticals
Key Employee Changes
Date | New article |
---|---|
2021-12-01 | Ironwood Pharmaceuticals Appoints Sravan K. Emany as Chief Financial Officer |
2021-08-03 | Ironwood Pharmaceuticals Appoints John Minardo as Chief Legal Officer |
2021-02-08 | Ironwood Pharmaceuticals Announces CEO Transition |
Official Site Inspections
http://www.ironwoodpharma.com Semrush global rank: 3.97 M Semrush visits lastest month: 3.12 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago